Delly Chipta Lestari

Dr. Delly Chipta Lestari

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2016 in Majalah Kedokteran Andalas
Verified
Journal Article
Open access
PDF file
LLLinosefa Linosefa
Linosefa Linosefa
DLDelly Chipta Lestari
Delly Chipta Lestari
AKArdiana Kusumaningrum
Ardiana Kusumaningrum
AKAnis Karuniawati
Anis Karuniawati
AYAndi Yasmon
Andi Yasmon
Penilitian ini bertujuan untuk mengetahui prevalensi MRSA penghasil Panton-Valentine leukocidin (PVL) dan pola kepekaannya. Sampel penelitian adalah isolat MRSA dari 315 pasien Rumah Sakit Umum Pusat Nasional Cipto Mangunkusumo (RSUPNCM) selama tahun 2011 dan 2014, dengan melakukan identifikasi, uji kepekaan dan uji molekuler terhadap isolat tersebut. Penelitian ini menunjukkan sebanyak 59% dari koloni MRSA yang ditemukan masih sensitif terhadap antibiotik golongan selain β-laktam, sehingga masih dapat diduga sebagai community-associated MRSA (CA-MRSA). CA-MRSA sepertinya mulai ditransmisikan di fasilitas kesehatan. Uji molekuler terhadap isolat MRSA memberikan hasil 8,3% isolat MRSA menghasilkan PVL. Berdasarkan tipe pola kepekaannya isolat MRSA penghasil PVL tersebut masih dapat digolongkan sebagai CA-MRSA. MRSA penghasil PVL ditemukan di RSUPNCM sebagai kolonisasi. Surveilan perlu dilakukan untuk memahami interaksi antara MRSA di komunitas dan rumah sakit, terutama untuk mengurangi transmisi di fasilitas kesehatan.

3 February 2026 in Research Square
Verified
Preprint
Open access
PWPhoebe Williams
Phoebe Williams
NPNina Dwi Putri
Nina Dwi Putri
JHJackson Harrison
Jackson Harrison
BDBenjamin Dickson
Benjamin Dickson
DLDelly Chipta Lestari
Delly Chipta Lestari
CGClara Grazian
Clara Grazian
Antimicrobial resistance contributes to neonatal mortality globally. Delineating transmission pathways resulting in neonatal colonisation with multidrug-resistant (MDR) bacteria is necessary to reduce this burden. We conducted a prospective cohort study of 189 mother-infant dyads to delineate the risk factors associated with transmission of MDR bacteria, revealing a high prevalence of maternal colonisation with ESBL-producing bacteria at delivery (55%, 104/189) and in neonates by hospital discharge (61%, 115/189). Compared to non-colonised neonates, those colonised with MDR bacteria were more likely to have been exposed to antibiotics prior to colonisation (63%, vs 24%, p<0.001), require a longer hospital stay (16 days vs 2 days, p<0.001) and have episodes of sepsis following colonisation (62% vs 24%, p<0.001). However, most culture-positive neonatal infections (91%, 10/11) were not caused by previously identified colonising bacteria. Our study reveals poor clinical outcomes associated with MDR neonatal colonisation and suggests improved antibiotic stewardship programs may reduce this burden.

20 July 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
NPNina Dwi Putri
Nina Dwi Putri
JHJackson Harrison
Jackson Harrison
BDBenjamin F. R. Dickson
Benjamin F. R. Dickson
DLDelly Chipta Lestari
Delly Chipta Lestari
JRJessica Ramsay
Jessica Ramsay
PWPhoebe C. M. Williams
Phoebe C. M. Williams
Antimicrobial resistance contributes to neonatal mortality globally. Delineating transmission pathways resulting in neonatal colonisation with multidrug-resistant (MDR) bacteria is necessary to reduce this burden. We conducted a prospective cohort study of 189 mother-infant dyads to identify the risk factors associated with transmission of MDR bacteria, revealing a high prevalence of maternal colonisation with MDR bacteria at delivery (63%, 120/189), and in neonates by hospital discharge (61%, 115/189). However, maternal colonisation with carbapenem-resistant Enterobacterales (CRE) was low (3%, 6/189) whereas CRE acquisition occurred at a median time point of 13 days in hospitalised neonates (26%, 50/189), suggesting horizontal transmission of CRE predominates. Compared to non-colonised neonates, those colonised with MDR bacteria were more likely to have been exposed to antibiotics prior to colonisation (63%, vs 24%, p < 0.001), require a longer hospital stay (16 days vs 2 days, p < 0.001) and have episodes of sepsis following colonisation (62% vs 24%, p < 0.001). However, most culture-positive neonatal infections (91%, 10/11) were not caused by previously identified colonising bacteria. Our study reveals poor clinical outcomes associated with MDR neonatal colonisation, and suggests improved antibiotic stewardship strategies may reduce this burden.

29 June 2024 in Microbiology Research
Verified
Journal Article
Open access
PDF file
DLDelly Chipta Lestari
Delly Chipta Lestari
PSPranee Somboonthum
Pranee Somboonthum
DMDaisuke Motooka
Daisuke Motooka
EIEIJI ISHII
EIJI ISHII
SMShigeaki Matsuda
Shigeaki Matsuda
TITetsuya Iida
Tetsuya Iida
Pneumococcal pneumonia is a significant cause of illness and death globally, particularly among young children and the elderly. The cpsB gene is involved in the biosynthesis of the capsule polysaccharide, and polymorphisms in the cpsB gene are the basis for sequetyping, a molecular biology-based approach to serotyping. In this study, we attempted the sequetyping of pneumococci directly from clinical sputum specimens collected from adult patients diagnosed with community-acquired pneumonia (CAP). We performed conventional PCR for the cpsB gene, followed by TA cloning and Sanger sequencing of the amplicon. The results showed the status of clonality of pneumococci in each specimen. We also performed real-time PCR targeting pneumococci for each specimen. It revealed a significant association between the Ct value of the real-time PCR and the clonality status of pneumococci among the specimens (p-value 0.0007 by Fisher’s exact test analysis). Specifically, when the Ct value was below 22, there was a high probability that pneumococcus existed as a single clone. Thus, this study demonstrates the possible correlation between pneumococcal clonality and bacterial load in clinical specimens, which might indicate the infection status.

5 August 2026 in Jurnal Kesehatan Komunitas Indonesia
Verified
Journal Article
Open access
PDF file
DLDelly Chipta Lestari
Delly Chipta Lestari
PKPuspa Andhia Kemalasari
Puspa Andhia Kemalasari
RKRifka Kamila
Rifka Kamila
CEChesya Ejoli
Chesya Ejoli
WTWisnu Tafroji
Wisnu Tafroji
AAAlana Arumsari
Alana Arumsari
Background: Meningitis caused by Neisseria meningitidis remains a significant public health concern. A carriage study is crucial for understanding the distribution of Neisseria meningitidis serogroups in the community. The presence of Kingella denitrificans may lead to misidentification as N. meningitidis due to phenotypic similarity on blood agar. However, the prevalence of K. denitrificans in nasopharynx and oropharynx remains unclear. Objective: This study aimed to determine the prevalence of K. denitrificans as a mimicker of N. meningitidis in a carriage surveillance setting and to evaluate the role of MALDI-TOF MS in ensuring accurate bacterial identification. Methods: A cross-sectional study was conducted from September to December 2025 among unvaccinated adults in Jakarta with meningococcal disease. Oropharyngeal and nasopharyngeal swabs were collected and cultured on VCNT-supplemented blood agar. Preliminary identification was performed using colony morphology, Gram staining, and oxidase and catalase tests. Definitive identification was carried out using MALDI-TOF MS. Results: Among 228 participants, 11 (4.8%) carried Kingella spp. in the nasopharynx and/or oropharynx. All carriers were females aged 19–33 years (median age: 25 years). The isolates exhibited colony morphology similar to N. meningitidis, potentially leading to misidentification. However, they could be differentiated by their Gram staining morphology and catalase test results. MALDI-TOF MS identified 5 of 11 isolates (45.5%) as K. denitrificans with high-confidence log scores. Conclusion: K. denitrificans phenotypically might mimicked N. meningitidis in carriage surveillance but can be distinguished with Gram staining. The integration of MALDI-TOF MS is essential to improve diagnostic accuracy and prevent false-positive results. Further studies are needed to assess the feasibility of implementing this technology in resource-limited settings.